mNGS test to find germs in ventilated children
Part of Infections, Lungs & breathing clinical trials.
This trial looks at using a special test (mNGS) on samples from children on a breathing machine to identify the germ causing a respiratory infection. It may help doctors choose the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was admitted to the PICU (pediatric intensive care unit) and started an invasive breathing machine within the last 24 hours
- Your child is expected to have or has had more than 5 days of invasive breathing-machine support
- You agree in writing to let your child take part in this study
- Your child is not enrolled in another clinical study at the same time
- Your child has a respiratory tract infection that is being managed in the PICU
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a cocktail of bacteriophages (viruses that kill bacteria) can treat ventilator-associated pneumonia caused by hard-to-treat bacteria like Klebsiella, Acinetobacter, or Pseudomonas. It may help patients who have not responded to standard antibiotics.
This study checks whether a fast “DNA test” can help diagnose hospital-acquired or ventilator-associated pneumonia in very sick patients with sepsis. If the test is accurate, it may help doctors start the right treatment sooner.
This trial tests whether doctors can safely reduce or stop some antibiotics earlier for patients on breathing machines who develop pneumonia in the ICU. It looks at using lab results to guide treatment, which might lower side effects from unnecessary antibiotics.
This study tests a new way to quickly diagnose pneumonia in children on breathing machines in the ICU. It uses information from the body and germs to find the right treatment faster.
This trial uses a rapid test (PCR) to check for bacteria in your lung fluid, so doctors can pick the right antibiotics faster. It's for ICU patients on a breathing machine who may have a lung infection.
This trial tests whether using a fast respiratory test combined with a treatment plan can help doctors choose the right antibiotics sooner for patients in the intensive care unit who get pneumonia from a breathing machine. It aims to improve treatment and reduce unnecessary antibiotics.
Hear when a new VAP - Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.